Massachusetts Life Sciences Center

Summary

In 2006 was created Massachusetts Life Sciences Center, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Waltham. The venture was found in North America in United States.

The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Medical, Genetics. Among the various public portfolio startups of the fund, we may underline Candel, Massachusetts Biomedical Initiatives, Baystate Health For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of more than 20 years to get the investment from the fund.

The real fund results show that this Corporate Investor is 30 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this Massachusetts Life Sciences Center works on 17 percentage points less the average amount of lead investments. Deals in the range of 1 - 5 millions dollars are the general things for fund. The high activity for fund was in 2019. The fund is constantly included in 2-6 investment rounds annually. The top amount of exits for fund were in 2016.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Massachusetts Life Sciences Center, startups are often financed by National Institutes of Health, MassChallenge, National Science Foundation. The meaningful sponsors for the fund in investment in the same round are MassChallenge, Center for the Advancement of Science in Space. In the next rounds fund is usually obtained by National Science Foundation, National Institutes of Health, Massachusetts Office of International Trade and Investment (MOITI).